The Evolution of Therapies in Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

The Evolution of Therapies in Non-Small Cell Lung Cancer

Published:2015-09-09 Issue:3 Volume:7 Page:1815-1846
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Boolell Vishal,Alamgeer Muhammad,Watkins David,Ganju Vinod

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

http://www.mdpi.com/2072-6694/7/3/0864/pdf

Reference135 articles.

1. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancerhttp://globocan.iarc.fr

2. Non-small cell lung cancer;Ettinger;J. Natl. Compr. Cancer Netw.,2012

3. The changing epidemiology of lung cancer in Europe

4. Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes

5. SEER Cancer Statistics Review, 1975–2012,2015

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma;BMC Cancer;2024-01-17

2. Evolution of Lung Cancer Treatment from Classical Chemotherapy to Advanced Immunotherapy;Immunotherapy Against Lung Cancer;2024

3. The small-molecule kinase inhibitor ceritinib, unlike imatinib, causes a significant disturbance of lipid membrane integrity: A combined experimental and MD study;Chemistry and Physics of Lipids;2023-11

4. Advancement of regulating cellular signaling pathways in NSCLC target therapy via nanodrug;Frontiers in Chemistry;2023-09-07

5. Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds;Cancers;2023-08-05